Dr. Akshintala received his medical degree from the Andhra Medical College in India in 2011. Following this, he completed a post-doctoral research fellowship in Gastroenterology at Johns Hopkins Hospital where he established himself as a dedicated researcher. Dr. Akshintala completed his internship and residency training in Internal Medicine at the University of Pittsburgh Medical Center in 2016. He completed his fellowship in Gastroenterology at Johns Hopkins Hospital in 2019. Dr. Akshintala then completed additional fellowships in Advanced Endoscopy and Medical Pancreatology at the Johns Hopkins Hospital in 2021. As of July 1, 2021, Dr. Akshintala is an Assistant Professor of Medicine in the Division of Gastroenterology at Johns Hopkins Hospital.
Dr. Akshintala’s research is focused on the medical as well as endoscopic evaluation and treatment of inflammatory disorders of the pancreas. He is also interested in developing new devices and technologies for the care of patients with gastrointestinal disorders. Dr. Akshintala has conducted multi-national randomized-controlled trials and has won numerous awards at major national and international conferences for his research. He also has authored more than 60 original articles, editorials, book chapters and review articles. Dr. Akshintala has received grant funding from the American Society for Gastrointestinal Endoscopy (ASGE) and the Maryland State to support his research. As an innovator, Dr. Akshintala has patented new therapies for gastrointestinal bleeding and pancreas necrosis, a complication of acute pancreatitis.
An internationally recognized researcher conducting multi-national clinical trials, Dr. Akshintala holds an Adjunct Assistant Professor position at the Asian Institute of Gastroenterology in India, one of the largest gastroenterology hospitals in the world. Dr. Akshintala is a Ph.D. candidate with the Dutch Pancreatitis Study Group in the Netherlands, who have been pioneered landmark clinical trials related to pancreatitis.
Dr. Akshintala offers in-person clinic visits at the Baltimore location and also provides telemedicine visits for patients located in Maryland, Washington, D.C. and Virginia.